Mani Ramzi1, Aliraza Rezvani1, Mehdi Dehghani1. 1. Department of Medical Oncology and Hematology and Bone Marrow Transplantation, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
The article titled "GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study"[1] which was first published in International Journal of Hematology-Oncology and Stem Cell Research, Volume 9, Issue 1, pp. 10-14, has been republished on October 1, 2015, to correct some errors in the text as well as errors in the references. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected article are provided here for reference.